Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $1.238B (100.0% shares, 0.0% debt)

Holdings (30)

BMRN BIOMARIN PHARMACEUTICAL INC 12.8%
Value $159M Shares 1,831,035 Share Price $86.68 * Est. Cost/Share $83.16 Unrealized @ Report Date +13.2%
UTHR UNITED THERAPEUTICS CORP 11.2%
Value $139M Shares 627,514 Share Price $220.75 Est. Cost/Share $89.23 Unrealized @ Report Date +148.2%
— REVANCE THERAPEUTICS INC 10.7%
Value $132M Shares 5,228,609 Share Price $25.31 Est. Cost/Share $21.40 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 10.7%
Value $132M Shares 10,524,022 Share Price $12.56 * Est. Cost/Share $9.63 Unrealized @ Report Date +23.3%
INSM INSMED INC 10.0%
Value $124M Shares 5,889,491 Share Price $21.10 * Est. Cost/Share $17.79 Unrealized @ Report Date +6.6%
PRTA PROTHENA CORP PLC 9.1%
Value $113M Shares 1,657,458 Share Price $68.28 * Est. Cost/Share $21.46 Unrealized @ Report Date +200.6%
BIIB BIOGEN INC 8.8%
Value $109M Shares 381,282 Share Price $284.85 * Est. Cost/Share $264.98 Unrealized @ Report Date +12.4%
STAA STAAR SURGICAL CO 5.8%
Value $72.27M Shares 1,374,822 Share Price $52.57 * Est. Cost/Share $24.23 Unrealized @ Report Date +151.3%
ACAD ACADIA PHARMACEUTICALS INC 4.7%
Value $57.62M Shares 2,405,793 Share Price $23.95 * Est. Cost/Share $28.41 Unrealized @ Report Date -21.8%
— SAGE THERAPEUTICS INC 3.3%
Value $40.41M Shares 859,517 Share Price $47.02 Est. Cost/Share $46.62 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 2.1%
Value $26.38M Shares 74,605 Share Price $353.64 * Est. Cost/Share $149.18 Unrealized @ Report Date +113.5%
NVCR NOVOCURE LTD 1.9%
Value $23.99M Shares 578,118 Share Price $41.50 * Est. Cost/Share $63.11 Unrealized @ Report Date -1.6%
EHTH EHEALTH INC 1.8%
Value $22.02M Shares 2,739,379 Share Price $8.04 Est. Cost/Share $38.13 Unrealized @ Report Date -79.0%
ALKS ALKERMES PLC 1.5%
Value $18.89M Shares 603,400 Share Price $31.30 * Est. Cost/Share $22.36 Unrealized @ Report Date +35.4%
SNDX SYNDAX PHARMACEUTICALS INC 1.0%
Value $12.82M Shares 612,600 Share Price $20.93 Est. Cost/Share $16.84 Unrealized @ Report Date +23.7%
SRPT SAREPTA THERAPEUTICS INC 0.9%
Value $10.77M Shares 94,030 Share Price $114.52 * Est. Cost/Share $128.81 Unrealized @ Report Date 0.0%
— KARYOPHARM THERAPEUTICS INC 0.8%
Value $10.16M Shares 5,675,876 Share Price $1.79 Est. Cost/Share $16.36 Unrealized @ Report Date —
ANAB ANAPTYSBIO INC 0.7%
Value $8.771M Shares 431,224 Share Price $20.34 Est. Cost/Share $19.06 Unrealized @ Report Date +6.4%
— NEVRO CORP 0.4%
Value $4.735M Shares 186,259 Share Price $25.42 Est. Cost/Share $25.42 Unrealized @ Report Date —
GOSS GOSSAMER BIO INC 0.3%
Value $4.158M Shares 3,465,152 Share Price $1.20 Est. Cost/Share $2.02 Unrealized @ Report Date -38.4%
CYTK CYTOKINETICS INC 0.3%
Value $3.644M Shares 111,717 Share Price $32.62 * Est. Cost/Share $6.71 Unrealized @ Report Date +451.1%
TVTX TRAVERE THERAPEUTICS INC 0.2%
Value $2.551M Shares 166,069 Share Price $15.36 * Est. Cost/Share $23.56 Unrealized @ Report Date -22.8%
VNDA VANDA PHARMACEUTICALS INC 0.2%
Value $2.136M Shares 324,073 Share Price $6.59 * Est. Cost/Share $11.21 Unrealized @ Report Date -42.8%
RLMD RELMADA THERAPEUTICS INC 0.1%
Value $1.802M Shares 732,400 Share Price $2.46 * Est. Cost/Share $3.27 Unrealized @ Report Date -15.5%
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value $1.674M Shares 64,700 Share Price $25.87 * Est. Cost/Share $15.56 Unrealized @ Report Date +71.0%
— KEZAR LIFE SCIENCES INC 0.1%
Value $1.608M Shares 656,200 Share Price $2.45 Est. Cost/Share $5.16 Unrealized @ Report Date —
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $1.349M Shares 160,800 Share Price $8.39 * Est. Cost/Share $7.10 Unrealized @ Report Date +38.8%
— GRITSTONE ONCOLOGY INC 0.1%
Value $1.299M Shares 666,127 Share Price $1.95 Est. Cost/Share $9.42 Unrealized @ Report Date —
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.1%
Value $676K Shares 27,100 Share Price $24.93 * Est. Cost/Share $39.74 Unrealized @ Report Date -47.7%
URGN UROGEN PHARMA LTD 0.0%
Value $254K Shares 24,500 Share Price $10.35 * Est. Cost/Share $27.01 Unrealized @ Report Date -59.2%